Phases (wearephases.com): New Women-Focused Peptide Telehealth Platform (Launched November 2026)
Phases launched on 3 November 2026 as a US telehealth platform for compounded peptide prescriptions aimed at women. Who operates it, what its site lists, how the prescription process works, and what we could not verify.
Key takeaways
- WWD reported on 3 November 2026 that Phases, a telehealth platform founded by Lana and Joseph Elie-Meyers, “launches Tuesday”. The domain wearephases.com was registered on 30 January 2026.
- The site is operated by KIT Products, Co., a Delaware corporation doing business as PHASES. Medical services are provided by MD Integrations, an independent medical group. Phases says it does not practise medicine or pharmacy.
- On 4 November 2026 the site listed compounded prescription items including BPC-157, sermorelin, PT-141, oxytocin, NAD+, glutathione and tirzepatide combinations. Dispensing pharmacies are not named on the pages we read.
- Neutral spotlight only. No rating, no recommendation and no medical advice.
What is Phases?
Phases is a US telehealth platform that connects patients with independent licensed clinicians who may prescribe compounded peptide and related preparations, filled by licensed compounding pharmacies. It positions itself around women’s life stages. The site is operated by KIT Products, Co., “a Delaware corporation doing business as PHASES” (Terms of Sale). Its Terms of Service say PHASES “does not practice medicine or pharmacy” and that medical services are provided by MD Integrations, an independent medical group (Terms of Service) Observed.
When did Phases launch?
| Evidence | Date | Source |
|---|---|---|
| Domain registration (RDAP) | 30 January 2026 | rdap.org |
| Refund policy effective date (v1.2) | 1 September 2026 | refund policy |
| Public launch (press) | 3 November 2026, “launches Tuesday” | WWD |
The domain is about nine months old, but the launch press dates public availability to this week.
What does Phases say it offers?
- Listed items on 4 November 2026: BPC-157, glutathione, MIC + B12, NAD+ (injection and nasal spray), oxytocin nasal spray, PT-141 (injection and nasal spray), sermorelin, and tirzepatide with B12 or glycine, including “microdose” versions (catalogue) Observed.
- Prices shown: for example BPC-157 at $250 a month (shown as $175 for the first month) and sermorelin at $200 ($140 first month). A $20 consultation fee applies per encounter. The medication cost is held on the card and charged only if a prescription is issued Observed.
- At launch, per WWD: nine treatment options from $145 a month, fulfilled through “partner 503(a) compounding pharmacies”. WWD’s list did not include BPC-157, which was on the site when we checked Company claim.
- Coverage: “All fifty states”, with a clinician licensed in the patient’s state (FAQ) Company claim.
What can you see on the site?
| Item | What we saw on 4 Nov 2026 |
|---|---|
| Disclosures | “Compounded preparations are not FDA-approved. FDA does not review compounded medicines for safety, effectiveness or manufacturing quality before they are dispensed” (FAQ) Observed |
| Pharmacies | “Phases does not compound or manufacture medication. All prescriptions are compounded and labeled by an independent licensed pharmacy.” Pharmacy names not shown. Patients may direct a prescription to a pharmacy of their choice (Terms) Observed |
| COAs | “A certificate of analysis for your lot is available on request” via the clinician. No COAs are published on the site Observed |
| Clinicians | Provided through MD Integrations; complaints can go to the state medical board Observed |
| Policies | Refund and cancellation policy: no refunds once compounded or shipped, replacement for cold-chain failure or damage reported within 14 days. Terms governed by California law Observed |
| Contact | support@wearephases.com; 2600 W. Olive Ave, 5th Fl., Burbank, CA 91505 (contact page) Observed |
How does the HHS peptide policy relate to Phases’ BPC-157 listing?
Phases lists BPC-157 days after HHS published its enforcement discretion policy for 503A compounding of six peptides. That policy covers BPC-157 acetate for subcutaneous, intramuscular, oral and topical use, on a patient-specific prescription, as a single active ingredient, when ten conditions are met. It is not FDA approval. See HHS’s peptide compounding policy explained and BPC-157’s regulatory status. We did not check whether any specific Phases product meets those conditions.
What could not be verified?
- Which compounding pharmacies fill Phases prescriptions, and their licences. Could not independently verify.
- Whether its BPC-157 product matches the salt form, route and sourcing conditions of the HHS policy. Could not independently verify.
- The 50-state coverage claim and clinician licensure. Could not independently verify.
- Peptide Ad Lab has not used the service.
Phases does not yet have a profile in our company index. The company can claim or request a profile.
Sources
- WWD, Phases Launches With Women-Focused Peptide Treatments, 3 November 2026
- RDAP record for wearephases.com
- Phases: home · catalogue · FAQ · terms of service · terms of sale · refund policy · contact
Checked 4 November 2026. Company statements are labelled as claims. This spotlight is not medical advice and not a recommendation to use the service.
Reader Question
“Is Phases a pharmacy?”
Short Answer
No. It describes itself as a technology and administrative platform. Clinicians come from MD Integrations, and an independent licensed pharmacy compounds and labels the prescriptions.
Practical Recommendation
- Ask which pharmacy will fill the prescription and check its licence with your state board.
- Request the lot COA before treatment starts; Phases says it is available on request.
- Read the refund policy. Compounded medication cannot be returned once it has been made or shipped.
What we learned
New telehealth peptide platforms tend to share one structure: a technology company, an independent medical group and unnamed partner pharmacies. The terms of service, not the homepage, usually show who is responsible for each part. The pharmacy name is the detail most often left out, and it is the one a patient or a directory most needs.
Frequently asked
Who operates Phases?
KIT Products, Co., a Delaware corporation doing business as PHASES, according to its Terms of Sale. Medical services are provided by MD Integrations, an independent medical group.
When did Phases launch?
WWD reported on 3 November 2026 that the platform was launching that Tuesday. Its domain was registered on 30 January 2026.
Does Phases make its own medications?
No. The site says Phases does not compound or manufacture medication and that prescriptions are compounded and labelled by an independent licensed pharmacy.
Does Phases publish COAs?
Not on the site. Its FAQ says a certificate of analysis for your lot is available on request through your clinician.
Explore the directory
Compare companies, suppliers and testing laboratories in the Peptide Ad Lab index. Every profile separates what we verified from what a company claims.
Related articles
HHS’s Peptide Compounding Policy: The 6 Peptides Covered and the 10 Conditions
HHS published its enforcement discretion policy for 503A compounding of BPC-157, TB-500, KPV, MOTS-c, semax and epitalon on 30 October 2026. The cover…
Is BPC-157 Legal? Its US Regulatory Status After the HHS Policy (November 2026)
BPC-157 is not FDA-approved and not on the 503A bulks list. Since 30 October 2026, HHS has said it will not take enforcement action against 503A compo…
StackLab (withstacklab.com): New Compounded GLP-1 Telehealth Platform (Launched October 2026)
StackLab launched on 12 October 2026 as a US telehealth platform for compounded semaglutide and tirzepatide, with a wider peptide menu announced. What…